Healthcare provider profile · identity verified

Brian Edward Sullivan, M.D.

Internal Medicine · DUBUQUE, IA · NPI 1194771048

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	887	230
Losartan Potassium	Losartan Potassium	666	163
Amlodipine Besylate	Amlodipine Besylate	568	143
Omeprazole	Omeprazole	388	92
Hydrochlorothiazide	Hydrochlorothiazide	356	93
Rosuvastatin Calcium	Rosuvastatin Calcium	348	89
Metoprolol Succinate	Metoprolol Succinate	346	82
Levothyroxine Sodium	Levothyroxine Sodium	321	70
Furosemide	Furosemide	314	81
Lisinopril	Lisinopril	296	73
Tamsulosin Hcl	Tamsulosin Hcl	282	79
Spironolactone	Spironolactone	281	70
Simvastatin	Simvastatin	240	62
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	232	43
Famotidine	Famotidine	220	60
Potassium Chloride	Potassium Chloride	217	58
Gabapentin	Gabapentin	206	55
Escitalopram Oxalate	Escitalopram Oxalate	197	40
Metformin Hcl Er	Metformin Hcl	190	53
Pravastatin Sodium	Pravastatin Sodium	185	48
Allopurinol	Allopurinol	184	53
Eliquis	Apixaban	182	32
Metoprolol Tartrate	Metoprolol Tartrate	162	38
Pantoprazole Sodium	Pantoprazole Sodium	154	42
Xarelto	Rivaroxaban	140	20
Clopidogrel	Clopidogrel Bisulfate	129	28
Atenolol	Atenolol	128	33
Fluoxetine Hcl	Fluoxetine Hcl	122	22
Alendronate Sodium	Alendronate Sodium	121	39
Finasteride	Finasteride	118	31
Metformin Hcl	Metformin Hcl	118	25
Lovastatin	Lovastatin	109	23
Trazodone Hcl	Trazodone Hcl	104	27
Prednisone	Prednisone	99	40
Carvedilol	Carvedilol	97	27
Jardiance	Empagliflozin	95	17
Warfarin Sodium	Warfarin Sodium	95	13
Fluticasone Propionate	Fluticasone Propionate	91	28
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	90	25
Glimepiride	Glimepiride	70	21
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	70	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	61	14
Tramadol Hcl	Tramadol Hcl	61	14
Mirtazapine	Mirtazapine	60	15
Celecoxib	Celecoxib	54	13
Cephalexin	Cephalexin	54	47
Sertraline Hcl	Sertraline Hcl	53	13
Albuterol Sulfate Hfa	Albuterol Sulfate	51	17
Chlorthalidone	Chlorthalidone	50	suppressed
Duloxetine Hcl	Duloxetine Hcl	50	suppressed
Ropinirole Hcl	Ropinirole Hcl	49	suppressed
Paroxetine Hcl	Paroxetine Hcl	48	11
Lorazepam	Lorazepam	47	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	13
Ondansetron Odt	Ondansetron	40	19
Enalapril Maleate	Enalapril Maleate	39	suppressed
Ezetimibe	Ezetimibe	37	12
Glipizide Er	Glipizide	35	suppressed
Memantine Hcl	Memantine Hcl	35	suppressed
Glipizide	Glipizide	32	suppressed
Ibuprofen	Ibuprofen	32	suppressed
Azithromycin	Azithromycin	31	29
Diltiazem 24hr Er	Diltiazem Hcl	31	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Amoxicillin	Amoxicillin	28	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Clotrimazole	Clotrimazole	26	16
Labetalol Hcl	Labetalol Hcl	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Irbesartan	Irbesartan	24	suppressed
Estradiol	Estradiol	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	19
Arnuity Ellipta	Fluticasone Furoate	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	20	suppressed
Divalproex Sodium	Divalproex Sodium	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	17
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Methadone Hcl	Methadone Hcl	20	suppressed
Rybelsus	Semaglutide	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Clonazepam	Clonazepam	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Ozempic	Semaglutide	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Nitroglycerin	Nitroglycerin	18	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Baclofen	Baclofen	15	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Lactulose	Lactulose	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	12
Latanoprost	Latanoprost	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	suppressed
Fluconazole	Fluconazole	13	12
Hydrocortisone	Hydrocortisone	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Temazepam	Temazepam	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Alprazolam	Alprazolam	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nystatin	Nystatin	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error